In addition, two mutations in low-density lipoprotein receptor-related protein 4 (LRP4) have been found in sclerosteosis patients, independent of the sclerostin genotype, demonstrating that LRP4 interacts with sclerostin or mediates its function [11,12,13]. This evidence concerns the gene SOST and sclerosteosis.